Global Analgesics Market: Overview
Analgesics, or painkillers, are used to reduce and treat aches and
pains. Internal and external analgesics are used to combat pain
resulting from inflammation, cancer treatments, physiological injury,
neuropathic conditions, surgeries, wounds, and phantom aches. The
most prominent therapeutic classes of analgesics are local
anesthesia, nonsteroidal anti-inflammatory drugs (NSAIDs), and
opioids. The growing incidence of cancer worldwide and the rise in
chronic diseases are mainly responsible for the consistent growth of
the global analgesics market.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12113
The research publication offers clients a comprehensive summary of
the global analgesics market and elucidates the various factors
driving and hampering its growth during the forecast period. The
report also evaluates the chief players competing in the global
market for analgesics and profiles them on the basis of a number of
key attributes, such as company and business overview, recent
developments, product portfolio, business strategies, and financial
strength.
Global Analgesics Market: Key Trends and Competitive Landscape
The increasing therapeutic benefits offered by analgesics, in
addition to effective and fast relief from pain, have significantly
driven the demand for analgesics over the years. The development of
innovative drugs and rising awareness about these treatment options
have also supported the analgesics market. Moreover, the rise in
recurring aches and pains owing to an increase in the prevalence of
cancer, cardiovascular disease, arthritis, and other chronic and
acute diseases has propelled the demand for analgesics. Other key
factors positively impacting the global analgesics market include the
growing prevalence of pain worldwide, the rise in effective treatment
options, a surge in the aging population, and the growing acceptance
of analgesics by a wider target audience.
Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Bayer AG,
F. Hoffmann-La Roche Ltd., Pfizer Inc., Endo Pharmaceuticals, Reckitt
Benckiser plc, Bristol-Myers Squibb, Sanofi, Johnson & Johnson,
Novartis AG, and GlaxoSmithKline PLC are some of the major companies
actively participating in the global analgesics market. In the quest
of increasing their share in the analgesics market, an increasing
number of firms have been adopting acquisitions as their main
development strategy.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=12113
Global Analgesics Market: Region-wise Outlook
The global analgesics market has been categorized into Europe, North
America, Asia Pacific, and Rest of the World based on geography.
North America is presently the leading market for analgesics and is
projected to retain its dominant position through 2024. Recent
regulatory changes in the U.S., accompanied by new marketing
strategies by analgesics companies, have greatly benefited this
regional market. After declining sales owing to frequent recalls, the
analgesics market in the U.S., in particular, has been stabilizing on
account of the return of prominent brands, the rising occurrence of
aches and pains, the rise in the average age of the population, and
an alarming rate of obesity. These demographic and lifestyle
developments have significantly propelled the North America
analgesics market.
The Europe analgesics market is also anticipated to expand in the
coming years owing to the rapid commercialization of new drugs and an
increasing geriatric population. Although analgesics form one of the
largest product areas in over-the-counter drugs, this segment has
been negatively affected by the growing trend of improving health
instead of merely treating symptoms. An increasing number of
consumers in the U.K., for instance, have restricted their
consumption of analgesics with this trend in mind, thereby negatively
impacting the sales of analgesics.
In contrast, consumers in several Asia Pacific countries seem
relatively less concerned over the possible side-effects of
analgesics. A higher willingness to self-medicate instead of visiting
a trained physician for mild pain and fever is a trend that is common
in a number of countries, more prominently in India. Moreover, the
immensely stressful lifestyles in most urban parts of the region have
resulted in consumers looking for quick and easy solutions to combat
pain. This, combined with the surge in purchasing power, has enabled
the demand for as well as sales of analgesics to remain steady over
the years.
Request for the TOC of the Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=12113
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment